Association ofBDNFVal66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease is a research paper published in JAMA Neurology (2022). On theSindex it has a DataRank of 1.2. It has been cited 37 times, with 32 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.546
From this paper's citation signal
Citation Network Contribution
0.648
From 24 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 32 citers.
Medical Research Council
Grant: UKDRI-1001
NIA NIH HHS
Grant: U24 AG021886
NIA NIH HHS
Grant: U19 AG032438
National Health and Medical Research Council (NHMRC)
Grant: 1147465
A multi-cohort investigation of the effects of BDNF Val66Met on tau, neurodegeneration and cognition in preclinical Alzheimer’s disease
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U19AG032438-03
DIAN Genetics Core
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
FWCI
3.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals